Skip to main content

Dexterra Announces Date of Q3 2024 Results and Conference Call

By: Newsfile

Toronto, Ontario--(Newsfile Corp. - October 21, 2024) - Dexterra Group Inc. (TSX: DXT) ("Dexterra") announces that it intends to release its Q3 2024 results on November 5, 2024, after market close and has scheduled a conference call and webcast to begin promptly at 8:30 a.m. Eastern Time on November 6, 2024. A presentation will be posted on the Dexterra website at dexterra.com on November 5, 2024, to be reviewed on the conference call.

The conference call dial in number is 1-844-763-8274

A live webcast of the conference call will be accessible on Dexterra's website at dexterra.com/investor-presentations-events/ by selecting the Q3 2024 Results webcast link.

An archived recording of the conference call will be available approximately one hour after the completion of the call until December 6, 2024, by dialing 1-855-669-9658, passcode 5076311.

About Dexterra

Dexterra employs over 9,000 people, delivering a range of support services for the creation, management, and operation of infrastructure across Canada and the U.S.

Powered by people, Dexterra brings best-in-class regional expertise to every challenge and delivers innovative solutions, giving clients confidence in their day-to-day operations. Activities include a comprehensive range of integrated facilities management services, industry-leading workforce accommodation solutions, and other support services for diverse clients in the public and private sectors.

For further information contact:

Denise Achonu, CFO
Head office: Airway Centre, 5925 Airport Rd., Suite 1000 Mississauga, Ontario L4V 1W1 Telephone: (905) 270-1964

You can also visit our website at dexterra.com

To view the source version of this press release, please visit https://www.newsfilecorp.com/release/227276

Data & News supplied by www.cloudquote.io
Stock quotes supplied by Barchart
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy and Terms and Conditions.